The role of enzalutamide in the treatment of castration-resistant prostate cancer

Author： Rawlinson Alex Mohammed Aza Miller Marek Kunkler Roger

ISSN： 1479-6694

Source： Future Oncology, Vol.8, Iss.9, 2012-09, pp. : 1073-1081

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytotoxic Compounds in the Treatment of Castration-Resistant Prostate Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1040-1045

Bentham Science Publishers

Access to resources Recommend Favorite

Novel strategies in the treatment of castration-resistant prostate cancer (Review)

International Journal of Oncology, Vol. 40, Iss. 5, 2012-01 ,pp. : 1313-1320

Spandidos Publications

Access to resources Recommend Favorite

Quality of Life Associated with Treatment of Castration-Resistant Prostate Cancer: A Review of the Literature

By Moul Judd W. Dawson Nancy

Cancer Investigation, Vol. 30, Iss. 1, 2012-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

Is there an optimal treatment sequencing strategy for metastatic castration-resistant prostate cancer?

By Aragon-Ching Jeanny B

Future Oncology, Vol. 9, Iss. 5, 2013-05 ,pp. : 619-622

Future Medicine

Access to resources Recommend Favorite

Molecular mechanisms of castration-resistant prostate cancer progression

By Dutt Smitha S Gao Allen C

Future Oncology, Vol. 5, Iss. 9, 2009-11 ,pp. : 1403-1413

Future Medicine

Access to resources Recommend Favorite